By immunoblot analysis, our data showed a decreased expression level of LC3-II with an increased level of SQSTM1, cleaved PARP, and caspase 9/3 in tumor of T-DM1 combined with LY294002 group versus T-DM1-treated group (Fig. 5D). This evidence concerns the gene SQSTM1 and neoplasm.